Breaking Updates in Hematological-Oncology

The American Society of Hematology (ASH) 2021 Annual Meeting and Exposition was held in Atlanta on the 11-14 December. ASH has successfully honed the hybrid model and showcased outstanding leaps in understanding and treatment in 2021, across malignancies. Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.
View all videos

ASH 2021

The 63rd ASH Annual Meeting and Exposition
11–14 December 2021 | Atlanta, GA

#TXMPN22 | @harrisoncn1 discusses novel targets and combinations being explored in MPNs:

👉http://ow.ly/70he50KOSG1👈

#MPNsm #HemOnc #BloodCancerAwarenessMonth

We spoke to @anniencowan (@DanaFarber) at #IMS2022, who shared some updates from the PROMISE study, which is screening high-risk individuals for precursor conditions such as MGUS and MGIP:

🎥: http://ow.ly/ibfm50KOSf3

@Myeloma_Society #MMsm #HemOnc #BloodCancerAwarenessMonth

We're pleased to bring you another podcast! 🤩

Join experts Heinz Ludwig & Meral Beksac, who discuss the importance of identifying high-risk myeloma & future therapeutic strategies for this patient population.

🎧: http://ow.ly/2Top50KQC0l

#MMsm #HemOnc #ImmunoOnc

Join us this week in Houston, TX, as we interview experts & bring you exclusive discussions from #SOHO22! 👩‍⚕️👨‍⚕️

You won't want to miss out - follow us @VJHemOnc or visit http://VJHemOnc.com for more!

@SocietyofHemOnc #MMsm #LeuSM #AMLsm #ALLsm #LymSM #MDSsm #MPNsm #CLLsm

Load More...

ASH 2021

The 63rd ASH Annual Meeting and Exposition
11–14 December 2021 | Atlanta, GA

Breaking Updates in Hematological-Oncology

The American Society of Hematology (ASH) 2021 Annual Meeting and Exposition was held in Atlanta on the 11-14 December. ASH has successfully honed the hybrid model and showcased outstanding leaps in understanding and treatment in 2021, across malignancies. Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.
View all videos

#TXMPN22 | @harrisoncn1 discusses novel targets and combinations being explored in MPNs:

👉http://ow.ly/70he50KOSG1👈

#MPNsm #HemOnc #BloodCancerAwarenessMonth

We spoke to @anniencowan (@DanaFarber) at #IMS2022, who shared some updates from the PROMISE study, which is screening high-risk individuals for precursor conditions such as MGUS and MGIP:

🎥: http://ow.ly/ibfm50KOSf3

@Myeloma_Society #MMsm #HemOnc #BloodCancerAwarenessMonth

We're pleased to bring you another podcast! 🤩

Join experts Heinz Ludwig & Meral Beksac, who discuss the importance of identifying high-risk myeloma & future therapeutic strategies for this patient population.

🎧: http://ow.ly/2Top50KQC0l

#MMsm #HemOnc #ImmunoOnc

Join us this week in Houston, TX, as we interview experts & bring you exclusive discussions from #SOHO22! 👩‍⚕️👨‍⚕️

You won't want to miss out - follow us @VJHemOnc or visit http://VJHemOnc.com for more!

@SocietyofHemOnc #MMsm #LeuSM #AMLsm #ALLsm #LymSM #MDSsm #MPNsm #CLLsm

Load More...

post-ASH 2021 iwAL Virtual Workshop - apply for registration

Register for the post-ASH 2021 iwMPNs Virtual Workshop

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter